Authors:
McEntegart, A
Capell, HA
Creran, D
Rumley, A
Woodward, M
Lowe, GDO
Citation: A. Mcentegart et al., Cardiovascular risk factors, including thrombotic variables, in a population with rheumatoid arthritis, RHEUMATOLOG, 40(6), 2001, pp. 640-644
Authors:
Hamilton, J
McInnes, IB
Thomson, EA
Porter, D
Hunter, JA
Madhok, R
Capell, HA
Citation: J. Hamilton et al., Comparative study of intramuscular gold and methotrexate in a rheumatoid arthritis population from a socially deprived area, ANN RHEUM D, 60(6), 2001, pp. 566-572
Authors:
Hamilton, JD
Gordon, MM
McInnes, IB
Johnston, RA
Madhok, R
Capell, HA
Citation: Jd. Hamilton et al., Improved medical and surgical management of cervical spine disease in patients with rheumatoid arthritis over 10 years, ANN RHEUM D, 59(6), 2000, pp. 434-438
Authors:
Maiden, N
Capell, HA
Madhok, R
Hampson, R
Thomson, EA
Citation: N. Maiden et al., Does social disadvantage contribute to the excess mortality in rheumatoid arthritis patients?, ANN RHEUM D, 58(9), 1999, pp. 525-529
Citation: Mm. Gordon et al., Does sulphasalazine cause drug induced systemic lupus erythematosus? No effect evident in a prospective randomised trial of 200 rheumatoid patients treated with sulphasalazine or auranofin over five years, ANN RHEUM D, 58(5), 1999, pp. 288-290
Citation: A. Crilly et al., Genotyping for disease associated HLA DR beta 1 alleles and the need for early joint surgery in rheumatoid arthritis: a quantitative evaluation, ANN RHEUM D, 58(2), 1999, pp. 114-117
Citation: Ha. Capell et K. Chaudhuri, The case for conservative treatment in rheumatoid arthritis, CHALLENGES IN RHEUMATOID ARTHRITIS, 1999, pp. 116-137